Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. (Q44195595)
Jump to navigation
Jump to search
scientific article published on 20 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. |
scientific article published on 20 June 2007 |
Statements
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial (English)
Andrea Gallamini
Caterina Patti
Atto Billio
Maria Rosaria Specchia
Alessandra Tucci
Alessandro Levis
Annunziata Manna
Vicenzo Secondo
Luigi Rigacci
Antonello Pinto
Emilio Iannitto
Valerio Zoli
Pierfederico Torchio
Corrado Tarella